Medicare coverage for Delstrigo is determined by individual Medicare Part D plans. The drug is approved for treating HIV-1 infection in adults and adolescents [1].
Can I get Delstrigo through Medicare Part D?
Whether Delstrigo is covered by a specific Medicare Part D plan depends on the plan's formulary, which is a list of covered prescription drugs. Patients should verify coverage with their chosen Medicare Part D plan [1].
What is Delstrigo?
Delstrigo is a single-tablet regimen that combines three antiretroviral medications: doravirine, lamivudine, and tenofovir disoproxil fumarate. It is prescribed for individuals with HIV-1 infection [1].
When did Delstrigo get approved?
The U.S. Food and Drug Administration (FDA) approved Delstrigo in February 2019 [1].
How much does Delstrigo cost?
The cost of Delstrigo can vary depending on insurance coverage, pharmacy, and other factors. Patients with Medicare Part D plans should consult their plan for specific cost information. Manufacturer savings programs may also be available [1].
Are there alternatives to Delstrigo covered by Medicare?
Medicare Part D plans cover a range of other HIV medications. Patients should discuss alternative treatment options with their healthcare provider to determine which is most suitable and best covered by their plan [1].